Filing Details
- Accession Number:
- 0001209191-18-049847
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-06 16:43:53
- Reporting Period:
- 2018-09-04
- Accepted Time:
- 2018-09-06 16:43:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1508798 | R Gary Maharaj | 9924 West 74Th Street Eden Prairie MN 55344 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-09-04 | 3,700 | $79.40 | 171,579 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-09-04 | 1,300 | $80.16 | 170,279 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
- Reflects the weighted average price of 3,700 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on September 4, 2018 with sale prices ranging from $78.90 to $79.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes 693 shares acquired through the Employee Stock Purchase Plan for the phase ending August 31, 2018.
- Reflects the weighted average price of 1,300 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on September 4, 2018 with sale prices ranging from $79.95 to $80.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
